2022–2023 mpox outbreak in Chile
2022–2023 mpox outbreak in Chile | |
---|---|
Disease | Mpox |
Virus strain | Monkeypox virus |
Location | Chile |
Index case | June 2022 |
Confirmed cases | 1,500 (as of October 2023) |
Deaths | 5 |
Government website | |
Ministry of Health |
The 2022–2023 mpox outbreak in Chile is part of the global outbreak of mpox, a viral disease caused by the Monkeypox virus. The outbreak in Chile began in June 2022, with the first confirmed case reported in the capital city, Santiago. Since then, the virus has spread to various regions across the country, prompting public health responses and vaccination campaigns.
Background[edit | edit source]
Mpox is a zoonotic disease caused by the Monkeypox virus, which is a member of the Orthopoxvirus genus. The disease is characterized by symptoms such as fever, headache, muscle aches, and a distinctive rash. While mpox is endemic to certain regions in Central Africa and West Africa, the 2022 outbreak marked a significant spread to non-endemic countries, including Chile.
Timeline of the Outbreak[edit | edit source]
June 2022[edit | edit source]
The first case of mpox in Chile was confirmed in June 2022. The patient had recently traveled to Europe, where they were likely exposed to the virus. Following this case, the Ministry of Health issued alerts and began contact tracing efforts.
July 2022[edit | edit source]
By July 2022, the number of confirmed cases had risen to 50. The government initiated a public awareness campaign to educate the population about the symptoms and transmission of mpox.
August 2022[edit | edit source]
In August, the Ministry of Health began a targeted vaccination campaign, prioritizing healthcare workers and individuals at higher risk of exposure. The campaign utilized the JYNNEOS vaccine, which is effective against mpox.
2023[edit | edit source]
Throughout 2023, the number of cases continued to rise, reaching a peak in March. By October 2023, there were approximately 1,500 confirmed cases and 5 reported deaths. The outbreak prompted ongoing public health measures, including isolation of confirmed cases and continued vaccination efforts.
Public Health Response[edit | edit source]
The Chilean government, through the Ministry of Health, implemented several measures to control the outbreak. These included:
- Surveillance and Contact Tracing: Enhanced surveillance systems were put in place to quickly identify and isolate new cases.
- Vaccination Campaigns: The government secured doses of the JYNNEOS vaccine and prioritized vaccination for high-risk groups.
- Public Education: Information campaigns were launched to inform the public about mpox symptoms, transmission, and prevention.
Impact on Society[edit | edit source]
The mpox outbreak in Chile has had significant social and economic impacts. Public fear and misinformation initially led to stigmatization of affected individuals. The government and health organizations worked to combat stigma through education and outreach.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD